Navigation Links
InspireMD Reports Fourth Quarter and Fiscal Year 2013 Results
Date:9/17/2013

activities.  Healthlink will provide InspireMD with customer service center capabilities for inquiries from hospitals and distributors.  Healthlink will also handle all inventory controls, warehousing, shipping, and invoicing and receivables management for customers worldwide on behalf of InspireMD.

The Company began enrollment with its MASTER II clinical trial to evaluate the safety and effectiveness of the MGuard™ Prime EPS in patients suffering from ST Elevation Myocardial Infarction (STEMI). In total, the multi-center, randomized trial is expected to include up to 70 sites in the U.S. and Europe and as many as 1,114 patients. The results are intended to support the Company's Investigational Device Exemption (IDE) application with the U.S. Food and Drug Administration (FDA) to market the MGuard™ Prime MicroNet™ covered coronary stent system in the U.S.

The ongoing progress and changes throughout the Company are being driven by new leadership brought in over the past year at the executive management and board levels. To lead the Company forward, Mr. Milinazzo was appointed President and CEO in January 2013, bringing fifteen years of experience in interventional cardiology to InspireMD. The Company also appointed Ms. Gwen Bame to a newly created position of Vice President of Corporate Development and charged her with identifying and executing strategic programs and partnerships designed to meet InspireMD's global growth objectives.  As of yesterday, the Company appointed Mr. David Blossom as its Vice President of Global Marketing and Strategy and will be charged with creating and overseeing the implementation of a global strategic marketing plan.  At the Board level, industry veterans, Mr. Michael Berman and Dr. Campbell Rogers recently joined to provide invaluable strategic guidance and support.

Fourth Quarter Financial ResultsRevenue for the quarter ended June 30, 2013 was $1.5 million, an increase of 60
'/>"/>

SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 /PRNewswire-USNewswire/ -- Kentucky,s ... doctor shopping after a 2012 law required providers to ... medications is yet more evidence that Californians need the ... Since Kentucky,s prescription drug abuse ... declined by 52 percent; opioid prescriptions to doctor-shopping individuals ...
(Date:7/28/2015)... 2015  SeraCare Life Sciences, a leading partner ... at the American Association of Clinical Chemistry (AACC) ... with the University of California, San Francisco (UCSF) ... 18 (T18) and Trisomy 13 (T13) trophoblast cell ... reference materials for Non-Invasive Prenatal Testing (NIPT) of ...
(Date:7/28/2015)... , July 28, 2015   Vincari , known ... , has just hired John O,Neil as ... John has over 30 years of diverse and progressive ... O,Neil,s executive healthcare experience coupled with Vincari,s CMO, Dr. ... allows Vincari to address the challenges both hospitals and ...
Breaking Medicine Technology:Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2
... Surgical Company (Nasdaq: STAA ), a leading ... today announced that it expects revenue for the fourth ... Revenues for the full year were approximately $55 million, ... increase of approximately 10% in revenues from the core ...
... Nalco (NYSE: NLC ), providing essential ... Water and Process Services division is implementing a price ... or as contracts permit.  Pricing for most Nalco programs ... product mix. Price increases will vary by country and ...
Cached Medicine Technology:STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 2STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 4Nalco Announces Price Increase 2Nalco Announces Price Increase 3
(Date:7/28/2015)... ... July 28, 2015 , ... Mindful Her, a unique ... to take their healthy and mindful living practices to the next level, announced today ... of Living with Intent as keynote. Global Girls, an Orange County based non-profit ...
(Date:7/28/2015)... ... July 28, 2015 , ... The Denver Foundation and ... Reframed and Exhibited,” a photographic and narrative exploration of African American giving, which ... Points neighborhood. , Denver is one of only ten cities to host “The ...
(Date:7/28/2015)... ... 2015 , ... Representatives with CareMed Urgent & Primary Care ... National Immunization Awareness Month, which is the month of August. , “Immunization helps ... the flu, measles, and pneumonia, adults need to get their shots – just ...
(Date:7/28/2015)... FAIRFAX, Virginia (PRWEB) , ... July 28, 2015 , ... ... in the Washington, D.C. technology community for over 20 years, has selected Lisa Dezzutti, ... for the upcoming year. , “I am excited to serve this organization that empowers ...
(Date:7/28/2015)... Diego, California (PRWEB) , ... July 28, 2015 , ... ... more women consider the procedure to help ensure future fertility. As Dr. Michael ... June 2015), egg freezing is an option that wasn’t available for previous generations who ...
Breaking Medicine News(10 mins):Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3
... with mammography systems in the, early detection of ... false-positives and patient recalls by estimated 60 ... 14 Parascript, LLC, the image,analysis and pattern ... medical imaging market. With over a dozen years,experience ...
... voices of frustration from,those who live with the ... heard.,Recent studies suggest that the comprehensive and often ... the point,of inaction. Studies show that nearly 63% ... treatment goals. "Understanding the lengthy,and challenging process of ...
... Product Sales Total $3.1 Million in Quarter; Amoxicillin PULSYS ... Review Ongoing - PDUFA ... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical ... financial and operational results for the quarter ended September,30, ...
... NeoGenomics, Inc.,(OTC Bulletin Board: NGNM), a premier, high-complexity cancer ... of FY 2007.,Significant accomplishments during the third quarter and ... following: Third Quarter 2007 Accomplishments: -- 95% ... 06 -- 33% sequential growth in revenue from ...
... CTI,s new cancer drug development platform, SEATTLE, ... first-hand the progress and prospects of three of ... MTAX: CTIC) oncology drug,candidates, as well as information ... from an international panel of clinical investigators at ...
... ... Jordan, FREDERICK, Md., ... Jordan Food,& Drug Administration has cleared ActiPatch for sale. The Company has,initiated ... "We are proud to announce another step for our Company in ...
Cached Medicine News:Health News:Parascript Enters Medical Imaging Breast Cancer Detection Market With Established Image Analysis Technology 2Health News:Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment 2Health News:Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 2Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 4Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 5Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 6Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 7Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 8Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 9Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 10Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 11Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 12Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 13Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 14Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 2Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 3Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 4Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 5Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 6Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 7Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 8Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 2Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 3Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 4Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 5Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 6Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 7Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 8Health News:ActiPatch(TM) Granted Market Clearance by the Food & Drug Administration in the Kingdom of Jordan 2
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support....
15mm Open Blades, 30mm Maximum Blade Spread; in Titanium....
9mm Gently Curved Jaws, without lock; in Titanium....
Medicine Products: